Free Trial

Alignment Healthcare (ALHC) Stock Forecast & Price Target

Alignment Healthcare logo
$12.05 -0.05 (-0.41%)
(As of 11/22/2024 ET)

Alignment Healthcare - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
3
Buy
8

Based on 12 Wall Street analysts who have issued ratings for Alignment Healthcare in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 1 has given a sell rating, 3 have given a hold rating, 6 have given a buy rating, and 2 have given a strong buy rating for ALHC.

Consensus Price Target

$10.33
-14.25% Downside
According to the 12 analysts' twelve-month price targets for Alignment Healthcare, the average price target is $10.33. The highest price target for ALHC is $12.00, while the lowest price target for ALHC is $7.00. The average price target represents a forecasted downside of -14.25% from the current price of $12.05.
Get the Latest News and Ratings for ALHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Alignment Healthcare and its competitors.

Sign Up

ALHC Analyst Ratings Over Time

TypeCurrent Forecast
11/24/23 to 11/23/24
1 Month Ago
10/25/23 to 10/24/24
3 Months Ago
8/26/23 to 8/25/24
1 Year Ago
11/24/22 to 11/24/23
Strong Buy
2 Strong Buy rating(s)
2 Strong Buy rating(s)
2 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
7 Buy rating(s)
4 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$10.33$9.83$10.05$10.23
Forecasted Upside-14.25% Downside-7.58% Downside8.41% Upside39.69% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

ALHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ALHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Alignment Healthcare Stock vs. The Competition

TypeAlignment HealthcareMedical CompaniesS&P 500
Consensus Rating Score
2.75
2.80
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside-14.25% Downside27,098.21% Upside7.66% Upside
News Sentiment Rating
Positive News

See Recent ALHC News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/30/2024Barclays
3 of 5 stars
 Boost TargetUnderweight ➝ Underweight$7.00 ➝ $8.00-30.80%
10/30/2024UBS Group
4 of 5 stars
 Boost TargetNeutral ➝ Neutral$9.00 ➝ $12.00+5.73%
10/11/2024KeyCorp
3 of 5 stars
M. Gillmor
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Weight
8/14/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$10.00 ➝ $11.00+29.56%
8/6/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$8.00 ➝ $10.00+9.53%
8/6/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Tassan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$8.00 ➝ $10.00+7.76%
7/26/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$9.00 ➝ $12.00+27.93%
5/30/2024Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/30/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$7.75 ➝ $11.00+57.59%
5/3/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$6.00 ➝ $7.00+5.42%
3/6/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform
1/9/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy ➝ Strong-Buy$10.00 ➝ $12.00+33.33%
8/30/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$19.00 ➝ $12.00+99.67%
7/7/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$12.00 ➝ $10.00+79.86%
5/5/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$24.00 ➝ $12.00+75.18%
4/19/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$14.00 ➝ $12.00+128.14%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 05:36 PM ET.


ALHC Forecast - Frequently Asked Questions

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Alignment Healthcare is $10.33, with a high forecast of $12.00 and a low forecast of $7.00.

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alignment Healthcare in the last year. There is currently 1 sell rating, 3 hold ratings, 6 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ALHC shares.

According to analysts, Alignment Healthcare's stock has a predicted downside of -14.25% based on their 12-month stock forecasts.

Alignment Healthcare has been rated by research analysts at Barclays, KeyCorp, and UBS Group in the past 90 days.

Analysts like Alignment Healthcare less than other "medical" companies. The consensus rating score for Alignment Healthcare is 2.75 while the average consensus rating score for "medical" companies is 2.80. Learn more on how ALHC compares to other companies.


This page (NASDAQ:ALHC) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners